Thermo Fisher Scientific Inc. (BVMF:TMOS34)

Market Cap	1.26T
Revenue (ttm)	233.65B
Net Income (ttm)	35.10B
Shares Out	n/a
EPS (ttm)	92.51
PE Ratio	35.90
Forward PE	26.01
Dividend	0.13 (0.19%)
Ex-Dividend Date	Dec 12, 2025

Volume	15,301
Average Volume	6,657
Open	69.51
Previous Close	69.56
Day's Range	69.46 - 70.15
52-Week Range	44.33 - 74.60
Beta	0.91
RSI	63.33
Earnings Date	Jan 29, 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: TMOS34

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD